Similar articles

• A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.

  Gharabawi GM, Bossie CA, Pandina GJ, Kujawa MJ, Greenspan AJ, Zhu Y. Gharabawi GM, et al. J Clin Psychiatry. 2007 Feb;68(2):333; author reply 334. doi: 10.4088/jcp.v68n0221a. J Clin Psychiatry. 2007. PMID: 17335334 No abstract available.
• Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.

  Kelly DL, Conley RR. Kelly DL, et al. J Clin Psychiatry. 2005 Jan;66(1):80-4. doi: 10.4088/jcp.v66n0111. J Clin Psychiatry. 2005. PMID: 15669892 Clinical Trial.
• A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.

  Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK. Potkin SG, et al. Schizophr Res. 2006 Jul;85(1-3):254-65. doi: 10.1016/j.schres.2006.03.027. Epub 2006 Jun 21. Schizophr Res. 2006. PMID: 16797162 Clinical Trial.
• Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.

  Nasrallah HA, Tandon R. Nasrallah HA, et al. J Clin Psychiatry. 2002;63 Suppl 13:12-20. J Clin Psychiatry. 2002. PMID: 12562142 Review.
• [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].

  Erbe S, Gutwinski S, Bschor T. Erbe S, et al. Psychiatr Prax. 2012 Mar;39(2):57-63. doi: 10.1055/s-0031-1277013. Epub 2011 Dec 21. Psychiatr Prax. 2012. PMID: 22189902 Review. German.